Price From:

€9533EUR$10,000USD£8,126GBP

Home /
Pharmaceuticals /
Biopharmaceuticals /
Vaccines /
Synagis

Synagis

Report
20 Pages
October 2018
Region: Global
Citeline
ID: 4775364

Description Jump to:

Description
Table of Contents
Related Topics
Related Reports
Purchase Options
Ask a Question
Recently Viewed Products

Overview
Synagis is a humanized antibody inhibitor of the RSV fusion (F) protein.

By blocking the interaction of the RSV F protein with the cell membrane, Synagis inhibits viral entry into host cells and also prevents cell-to-cell fusion of infected cells.

Passive immunization with Synagis is initiated at the start of the RSV season and requires a total of five monthly doses to maintain protection across the entire period.

TABLE OF OVERVIEW

Drug Overview
Product Profiles
Synagis : Respiratory syncytial virus (RSV) vaccines

LIST OF FIGURES

Figure 1: Synagis for respiratory syncytial virus – SWOT analysis
Figure 2: Synagis sales for RSV across the US and five major EU markets, 2016/17–2025/26

LIST OF TABLES

Table 1: Synagis drug profile
Table 2: Synagis Phase III data in RSV
Table 3: Recommendations for palivizumab immunization by national authorities, 2018
Table 4: Synagis sales for RSV across the US and five major EU markets, by country ($m), 2016/17–2025/26

Related Reports

SYNAGIS Market Size, Forecast, and Market Insight - 2032

 Report
30 Pages
April 2024
Global

From

€2622EUR$2,750USD£2,235GBP

Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030

 Report
115 Pages
August 2023
Global

From

€2145EUR$2,250USD£1,828GBP

ABRYSVO Market Size, Forecast, and Market Insight - 2032

 Report
30 Pages
April 2024
Global

From

€2622EUR$2,750USD£2,235GBP

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
181 Pages
November 2023
Global

From

€4671EUR$4,900USD£3,982GBP

Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034

 Report
200 Pages
January 2024
Global

From

€3956EUR$4,150USD£3,372GBP

This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.

PURCHASE OPTIONS

This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below.

€9533EUR$10,000USD£8,126GBP

Single User License PDF

This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF.

€46714EUR$49,000USD£39,817GBP

Enterprise License PDF

This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.

need a quote ?

View Pricing

HAVE A QUESTION? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Google Reviews

4.8



280 reviews

OUR CLIENTS

RECENTLY VIEWED PRODUCTS

Our Clients

Synagis

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.

Request a Quote

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

Please complete the below form and click "send request" to obtain a pdf quotation and order form.
This document will be available for immediate download and will also be emailed to you.

* Required Information

YOUR ADDRESS

Address 1*

Address 2

Address 3

City*

Postal/ZIP Code

Country*

State

Are you VAT registered?* Please note if you select 'Yes' and you are not VAT registered you may be liable to pay tax at a later date under the VAT reverse charge system.

VAT Number

YOUR DETAILS

Title

First Name*

Last Name*

Organisation*

Email Address* Please provide your business or academic email address.

Phone Number*

PO Number (if applicable)

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

PRODUCT FORMAT

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€9533EUR$10,000USD£8,126GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€46714EUR$49,000USD£39,817GBP

* The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change.

DOWNLOAD SAMPLE

Please fill in the information below to download the requested sample.

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Organisation*

Job Title*

Country*

Phone Number*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

Table of Contents

Related Topics

Related Reports

SYNAGIS Market Size, Forecast, and Market Insight - 2032

Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User (Adult and Maternal & Pediatric), By Type (Vaccine & Antibody), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2030

ABRYSVO Market Size, Forecast, and Market Insight - 2032

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034